Effect of Ageing on Airway Remodeling

NCT ID: NCT01230879

Last Updated: 2021-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-07-15

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the relationship between aging and morphological changes in the lung. 120 consecutive healthy volunteers over 60 years will be enrolled for this trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chest multidetector CT without injection and spirometry data will be obtained from a multicentric sample of individuals between 60 and 95 years of ageExclusion criteria were current smoking, history of smoking within the past 10 years, any known chronic or acute pulmonary disease. Individuals treated with Amiodarone, Bleomycin or methotrexate were excludedOutcome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Aging lung Airway remodeling Airway segmentation Chest CT

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

60 - 70 years old

EFR and TDM

Group Type EXPERIMENTAL

EFR and TDM

Intervention Type OTHER

EFR : Pulmonary function test TDM : tomodensitometry

71 - 80 years old

EFR and TDM

Group Type EXPERIMENTAL

EFR and TDM

Intervention Type OTHER

EFR : Pulmonary function test TDM : tomodensitometry

81 - 95 years old

EFR and TDM

Group Type EXPERIMENTAL

EFR and TDM

Intervention Type OTHER

EFR : Pulmonary function test TDM : tomodensitometry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EFR and TDM

EFR : Pulmonary function test TDM : tomodensitometry

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People from 60 to 95 years old free from chest disease or history of chest disease

Exclusion Criteria

* Chronic cough
* Dyspnea
* Sinonasal or chest infection during enrollment
* Myocardial infarction.
* Current smoker or past smoker with more than 10 pack year intoxication
Minimum Eligible Age

60 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

BOMMART Sebastien, MD

Role: PRINCIPAL_INVESTIGATOR

University Montpellier Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Montpellier Hospital

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Bommart S, Marin G, Bourdin A, Molinari N, Klein F, Hayot M, Vachier I, Chanez P, Mercier J, Vernhet-Kovacsik H. Relationship between CT air trapping criteria and lung function in small airway impairment quantification. BMC Pulm Med. 2014 Feb 28;14:29. doi: 10.1186/1471-2466-14-29.

Reference Type RESULT
PMID: 24581147 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8268

Identifier Type: -

Identifier Source: org_study_id